Status:
UNKNOWN
Assessment of Dissociative Traumatic Disorders
Lead Sponsor:
Januel
Conditions:
Posttraumatic Stress Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
More than 70% of ambulatory patients with IDD have attempted suicide (APA, 2015). This disorder, as well as all the disorders on the dissociation spectrum, must therefore be clarified and better diagn...
Eligibility Criteria
Inclusion
- Patient diagnosed with PTSD according to DSM 5 criteria
- Over 18 years of age
- Informed consent signed
Exclusion
- Neurological disorders
- Serious and/or unstable somatic pathologies
- Patient not affiliated with social security
- Patient hospitalized under restraint in psychiatric care by decision of the state representative or in psychiatric care at the request of a third party
- Patient under guardianship
- Patient participating in parallel in another biomedical research
- Change of antidepressant in the last three months
- Patient not mastering the French language
Key Trial Info
Start Date :
February 5 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 5 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04379648
Start Date
February 5 2019
End Date
September 5 2021
Last Update
May 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Youcef BENCHERIF
Neuilly-sur-Marne, Île-de-France Region, France, 93330